English
Home > Products > 81098-60-4

China 81098-60-4 Factory

owing to excellent support, a variety of top of the range items, aggressive rates and efficient delivery, we enjoy a very good reputation among our clients. We have been an energetic firm with wide market for 81098-60-4,CAS NO 81098-60-4,Cisapride API,Cisapride, We sincerely welcome domestic and foreign merchants who calls, letters asking, or to plants to negotiate, we will offer you quality products and the most enthusiastic service,We look forward to your visit and your cooperation.
81098-60-4, In order to carry out our goal of "customer first and mutual benefit" in the cooperation, we establish a expert engineering team and a sales team to supply the best service to satisfy our customers' requirements. Welcome you to cooperate with us and join us. We are your best choice.

Related Products

Hot Products

  • Linocaine hydrochloride

    Linocaine hydrochloride

    Product Name:Linocaine hydrochloride
    Molecular Formula:C14H25ClN2O2
    Molecular Weight;288.82
    CAS Registry Number;6108-05-0
  • Syringaldehyde

    Syringaldehyde

    Product Name:Syringaldehyde
    Molecular Formula:C9H10O4
    Molecular Weight;182.17
    CAS Registry Number;134-96-3
  • Oteseconazole

    Oteseconazole

    Product Name:Oteseconazole
    Molecular Formula:C23H16F7N5O2
    Molecular Weight;527.4
    CAS Registry Number;1340593-59-0
  • (R)-3-Amino-1-Butanol

    (R)-3-Amino-1-Butanol

    Product Name:(R)-3-Amino-1-Butanol
    Molecular Formula:C4H11NO
    Molecular Weight:89.14
    CAS Registry Number:61477-40-5
  • Cladribine

    Cladribine

    Product Name:Cladribine
    Molecular Formula:C10H12ClN5O3
    Molecular Weight;285.69
    CAS Registry Number;4291-63-8
  • Alectinib intermediate

    Alectinib intermediate

    Product Name:Alectinib intermediate
    Molecular Formula:C34H44N4O3
    Molecular Weight:556.74
    CAS Registry Number:1256698-41-5
  • Related Blog
  • Reviews

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 81098-60-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept